Andrew Seth Sandler's Net Worth
$89.9 Thousand
Who is Andrew Seth Sandler?
Andrew Seth Sandler does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Dermata Therapeutics, Inc., ALPINE IMMUNE SCIENCES, INC., and DENDREON CORP.
SEC CIK
Andrew Seth Sandler's CIK is 0001596060
Past Insider Trading and Trends
2022 was Andrew Seth Sandler's most active year for acquiring shares with 5 total transactions. Andrew Seth Sandler's most active month to acquire stocks was the month of December. 2014 was Andrew Seth Sandler's most active year for disposing of shares, totalling 13 transactions. Andrew Seth Sandler's most active month to dispose stocks was the month of December. 2022 saw Andrew Seth Sandler paying a total of $0.00 for 189,184 shares, this is the most they've acquired in one year. In 2015 Andrew Seth Sandler cashed out on 133,112 shares for a total of $11,734.01, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dermata Therapeutics, Inc. (DRMA) Snapshot price: $1.59
InvestorAndrew Seth Sandler owns 14,064 units of Common Stock, par value $0.0001 per share which is worth $22,361.76 and 24,184 units of Common Stock which is worth $38,452.56. From 2021 to 2024 Andrew Seth Sandler acquired a total of 24,184 shares in Dermata Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +71.96% | 10.12K |
—
|
—
| 24.18K |
Oct 6
| |||
Form 4
| +170.98% | 8.87K |
—
|
—
| 14.06K |
Jul 7
| |||
Form 4
|
∞
| 5.19K |
—
|
—
| 5.19K |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ALPINE IMMUNE SCIENCES, INC. (ALPN) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
DENDREON CORP No price found
EVP, Chief Medical OfficerAndrew Seth Sandler owns 207,914 units of Common Stock. In the year 2014 Andrew Seth Sandler acquired a total of 75,000 shares in DENDREON CORP, Andrew also disposed a total of 141,270 shares of DENDREON CORP equalling to $29,088.89.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.36% | -113.72K |
$0.09 | -$10,174.00 | 207.91K |
Feb 13
| |||
Form 4
| -1.87% | -6.12K |
$0.09 | -$532.53 | 321.63K |
Jan 13
| |||
Form 4
| -0.46% | -1.53K |
$0.08 | -$125.46 | 327.75K |
Jan 9
| |||
Form 4
| -3.44% | -11.74K |
$0.08 | -$902.02 | 329.28K |
Jan 3
| |||
Form 4
| -0.03% | -111.00 |
$1.03 | -$114.33 | 341.03K |
Oct 29
| |||
Form 4
| -0.37% | -1.28K |
$1.02 | -$1,307.64 | 341.14K |
Oct 9
| |||
Form 4
| -0.38% | -1.29K |
$1.36 | -$1,755.76 | 342.42K |
Oct 3
| |||
Form 4
| -0.03% | -111.00 |
$2.10 | -$233.10 | 343.71K |
Jul 29
| |||
Form 4
| -0.37% | -1.28K |
$2.27 | -$2,907.87 | 343.82K |
Jul 9
| |||
Form 4
| -0.37% | -1.29K |
$2.29 | -$2,956.39 | 345.1K |
Jul 3
| |||
Form 4
| -0.03% | -111.00 |
$2.53 | -$280.83 | 346.39K |
Apr 29
| |||
Form 4
| -0.37% | -1.28K |
$2.90 | -$3,717.80 | 346.5K |
Apr 9
| |||
Form 4
| -0.37% | -1.29K |
$2.93 | -$3,782.63 | 347.79K |
Apr 3
| |||
Form 4
| -0.03% | -107.00 |
$2.79 | -$298.53 | 349.08K |
Jan 29
| |||
Form 4
| +27.35% | 75K |
—
|
—
| 349.18K |
Jan 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |